| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.0B | $6.7B | $6.7B | $6.7B | $1.6B | $0.7B | $1.5B | $1.5B |
| Cost of Revenue | $1.7B | $1.8B | $1.9B | $2.0B | $1.7B | $1.7B | $2.0B | $2.0B |
| Gross Profit | $5.3B | $4.9B | $4.7B | $4.7B | $1.2B | $0.5B | $1.0B | $1.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.0B | $3.7B | $3.5B | — | — | $3.2B | $3.2B | $3.2B |
| Operating Income | $0.4B | $1.1B | $1.2B | $1.2B | $1.0B | $-0.6B | $0.8B | $0.7B |
| Net Income | $0.2B | $0.8B | $0.9B | $0.9B | $0.2B | $-0.3B | $0.1B | $0.2B |
| EPS (Basic) | $0.84 | $3.56 | $3.96 | $3.24 | $0.72 | $-1.06 | $0.51 | $0.74 |
| EPS (Diluted) | $0.82 | $3.50 | $3.88 | $3.17 | $0.69 | $-1.06 | $0.51 | $0.73 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.6B | $13.4B | $7.1B | $7.3B | $8.4B | $7.9B | $6.9B | $6.7B |
| Current Assets | $2.9B | $8.8B | $2.4B | $2.6B | $3.4B | $2.6B | $2.6B | $2.4B |
| Cash & Equivalents | $1.1B | $6.1B | $0.7B | $0.8B | $2.0B | $1.4B | $1.0B | $1.2B |
| Total Liabilities | $5.7B | $10.5B | $4.8B | $5.0B | $5.1B | $5.6B | $3.4B | $3.4B |
| Current Liabilities | $1.6B | $1.7B | $1.3B | $1.5B | $1.4B | $1.7B | $0.9B | $0.9B |
| Stockholders' Equity | $0.9B | $2.9B | $2.3B | $2.3B | $3.3B | $2.3B | $3.5B | $3.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.3B | $1.0B | $0.9B | $1.3B | $0.4B | $0.8B | $1.0B |
| Investing Cash Flow | $0.9B | $-1.0B | $0.0B | $-0.3B | $-0.1B | $0.0B | $-0.6B | $-2.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.2B | $0.3B | $0.3B |
| Financing Cash Flow | $-7.2B | $5.2B | $-1.0B | $-1.8B | $-0.7B | $0.0B | $-0.5B | $-0.2B |